These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 103824)

  • 21. Very large and isotypically atypical polyclonal plaque-forming cell responses in mice infected with Trypanosoma cruzi.
    D'Imperio Lima MR; Joskowicz M; Coutinho A; Kipnis T; Eisen H
    Eur J Immunol; 1985 Feb; 15(2):201-3. PubMed ID: 3918873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of extracts of Trypanosoma cruzi on immune responses: induction of a nonspecific suppressor factor.
    Tarleton RL; Schafer R; Kuhn RE
    Infect Immun; 1983 Sep; 41(3):978-86. PubMed ID: 6411623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: transfer of resistance to Brazil strain challenge with lymphocytes.
    Rowland EC; Ritter DM
    J Parasitol; 1984 Oct; 70(5):760-6. PubMed ID: 6439846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice?
    Starobinas N; Russo M; Minoprio P; Hontebeyrie-Joskowicz M
    Res Immunol; 1991 Feb; 142(2):117-22. PubMed ID: 1907750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection.
    Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P
    FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the thymus in modulating gammadelta T cell suppressor activity during experimental Trypanosoma cruzi infection.
    Cardillo F; Nomizo A; Mengel J
    Int Immunol; 1998 Feb; 10(2):107-16. PubMed ID: 9533438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi: flow cytometric analysis of lymphocyte subsets in susceptible and protected C3H/He mice.
    Powell MR; Rowland EC; Sidner RA
    Exp Parasitol; 1991 Aug; 73(2):197-202. PubMed ID: 1679718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of complement levels in mice infected with Trypanosoma cruzi.
    Cunningham DS; Craig WH; Kuhn RE
    J Parasitol; 1978 Dec; 64(6):1044-9. PubMed ID: 105116
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice.
    Kumar S; Tarleton RL
    J Immunol; 2001 Apr; 166(7):4596-603. PubMed ID: 11254717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells.
    Reed SG
    Infect Immun; 1980 May; 28(2):404-10. PubMed ID: 6772557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
    Reed SG
    J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner.
    Alba Soto CD; Mirkin GA; Solana ME; González Cappa SM
    Infect Immun; 2003 Mar; 71(3):1194-9. PubMed ID: 12595432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS; Tarleton RL
    J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of clones of the Brazil strain of Trypanosoma cruzi.
    Murfin DJ; Choromanski L; Kuhn RE
    J Parasitol; 1985 Oct; 71(5):525-9. PubMed ID: 3932632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of humoral immunity and lymphocyte responsiveness during experimental Trypanosoma cruzi infections.
    O'Daly JA; Simonis S; de Rolo N; Caballero H
    Rev Inst Med Trop Sao Paulo; 1984; 26(2):67-77. PubMed ID: 6433431
    [No Abstract]   [Full Text] [Related]  

  • 37. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of suppressed antibody responses in mice during experimental Chagas' disease by T helper cells activated in a time-dependent mode of immunization.
    Choromanski L; Kuhn RE
    J Protozool; 1990; 37(5):388-92. PubMed ID: 2145429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-antibody-mediated control of parasitemia in acute experimental Chagas' disease.
    Trischmann TM
    J Immunol; 1983 Apr; 130(4):1953-7. PubMed ID: 6403614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific suppression of delayed hypersensitivity expression to Trypanosoma cruzi in mice.
    Blotta MH; Curotto MA; Abrahamsohn IA
    Parasite Immunol; 1986 Nov; 8(6):651-61. PubMed ID: 3101033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.